From Nasdaq:

Alkermes (ALKS) closed at $28.20, more than the S&P 500. In the past month, the stock has gained 3.67%. The company is expected to report EPS of $0.42, up 200% from the previous year. Alkermes currently has a Zacks Rank of #3 and is trading at a discounted Forward P/E ratio of 12.34.

Their Medical – Biomedical and Genetics industry currently has a Zacks Industry Rank of 66, with promising outlooks. In the next trading sessions, keep an eye on the stock-shifting metrics. Stay tuned for updates on stock recommendations from Zacks Investment Research.

The electric vehicle revolution offers high potential for investors. Millions of lithium batteries are being made, and demand is predicted to increase by 889%. Download the brand-new FREE report revealing 5 EV battery stocks set to soar. Get the latest stock recommendations from Zacks Investment Research.



Read more: Alkermes (ALKS) Outpaces Stock Market Gains: What You Should Know